Magnum Experiment 48

Asset Allocation

Position	Category/Sector	Target Weight
AAPL Apple Inc	Technology	4.47%
ABBV AbbVie Inc.	Healthcare	4.88%
ADBE Adobe Inc	Technology	4.46%
BRK-B Berkshire Hathaway Inc.	Financial Services	7.82%
COST Costco Wholesale Corporation	Consumer Defensive	9.26%
HD The Home Depot, Inc.	Consumer Cyclical	4.79%
JNJ Johnson & Johnson	Healthcare	8.16%
KO The Coca-Cola Company	Consumer Defensive	7.20%
LLY Eli Lilly and Company	Healthcare	5.09%
MRK Merck & Co., Inc.	Healthcare	10.21%
PEP PepsiCo, Inc.	Consumer Defensive	7.02%
PG The Procter & Gamble Company	Consumer Defensive	7.75%
UNH UnitedHealth Group Incorporated	Healthcare	4.53%
V Visa Inc.	Financial Services	4.64%
WMT Walmart Inc.	Consumer Defensive	9.73%

Benchmark Against

Benchmark

S&P 500 Index

Rebalance

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 48, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Loading graphics...

The earliest data available for this chart is Jan 2, 2013, corresponding to the inception date of ABBV

Returns By Period

As of Apr 11, 2026, the Magnum Experiment 48 returned 3.49% Year-To-Date and 16.46% of annualized return in the last 10 years.

	1D	1M	YTD	6M	1Y	3Y*	5Y*	10Y*
Benchmark S&P 500 Index	-0.11%	2.16%	-0.42%	4.03%	27.10%	18.38%	10.55%	12.70%
Portfolio Magnum Experiment 48	-1.33%	-0.52%	3.49%	9.08%	14.18%	14.45%	14.24%	16.46%
Portfolio components:
MRK Merck & Co., Inc.	-1.03%	5.53%	16.21%	43.46%	58.92%	5.77%	14.31%	12.08%
WMT Walmart Inc.	-1.83%	1.36%	14.02%	24.99%	37.82%	37.91%	23.78%	20.76%
COST Costco Wholesale Corporation	-3.25%	-0.48%	15.94%	7.66%	4.21%	27.76%	23.76%	22.92%
JNJ Johnson & Johnson	-1.18%	-1.48%	15.84%	26.49%	61.54%	16.65%	11.23%	11.10%
BRK-B Berkshire Hathaway Inc.	-1.09%	-2.44%	-4.53%	-1.89%	-8.44%	15.22%	12.53%	12.92%
PG The Procter & Gamble Company	-1.02%	-3.55%	2.01%	-1.66%	-10.64%	1.32%	3.84%	8.70%
KO The Coca-Cola Company	-0.91%	0.51%	11.58%	17.17%	11.60%	10.62%	11.08%	8.55%
PEP PepsiCo, Inc.	-0.27%	-1.13%	10.41%	6.62%	13.10%	-1.69%	5.17%	7.32%
LLY Eli Lilly and Company	-1.65%	-3.87%	-12.44%	13.07%	29.22%	38.18%	39.87%	31.00%
ABBV AbbVie Inc.	-2.10%	-7.73%	-8.26%	-8.41%	22.77%	12.82%	18.55%	18.04%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jan 3, 2013, Magnum Experiment 48's average daily return is +0.06%, while the average monthly return is +1.33%. At this rate, an investment would double in approximately 4.4 years.

Historically, 66% of months were positive and 34% were negative. The best month was Oct 2022 with a return of +10.4%, while the worst month was Feb 2020 at -7.3%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.

On a daily basis, Magnum Experiment 48 closed higher 56% of trading days. The best single day was Mar 13, 2020 with a return of +9.0%, while the worst single day was Mar 16, 2020 at -9.6%.

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Total
2026	2.26%	6.41%	-5.64%	0.80%									3.49%
2025	3.28%	3.99%	-3.45%	-1.57%	-2.18%	-1.16%	-1.95%	5.63%	1.79%	0.37%	6.28%	-0.70%	10.21%
2024	4.45%	3.84%	1.26%	-3.15%	3.42%	2.86%	1.90%	6.64%	-0.67%	-3.03%	4.26%	-4.89%	17.44%
2023	-0.04%	-3.28%	4.52%	4.23%	-2.34%	5.96%	2.32%	0.31%	-3.35%	-0.28%	4.49%	2.58%	15.55%
2022	-1.60%	-2.35%	6.03%	-0.70%	-3.01%	-2.60%	5.06%	-4.12%	-5.17%	10.41%	6.15%	-3.30%	3.47%
2021	-3.31%	-2.11%	5.64%	3.09%	1.98%	2.60%	4.05%	1.81%	-4.83%	8.06%	-1.93%	7.42%	23.78%

Benchmark Metrics

Magnum Experiment 48 has an annualized alpha of 7.44%, beta of 0.70, and R² of 0.70 versus S&P 500 Index. Calculated based on daily prices since January 03, 2013.

This portfolio participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (89.74%) than losses (63.17%) — typical of diversified or defensive assets.
This portfolio generated an annualized alpha of 7.44% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
Beta of 0.70 indicates this portfolio moves significantly less than S&P 500 Index — a genuinely defensive profile with reduced participation in both market rallies and downturns.

Alpha: 7.44%

Beta: 0.70

R²: 0.70

Upside Capture: 89.74%

Downside Capture: 63.17%

Expense Ratio

Magnum Experiment 48 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

The portfolio doesn't include any funds that charge management fees.

Return for Risk

Risk / Return Rank

Magnum Experiment 48 ranks 15 for risk / return — in the bottom 15% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

Overall Rank

Sharpe Ratio Rank

Sortino Ratio Rank

Omega Ratio Rank

Calmar Ratio Rank

Martin Ratio Rank

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

	Portfolio	Benchmark	Difference
Sharpe ratio Return per unit of total volatility	1.31	2.23	-0.93
Sortino ratio Return per unit of downside risk	1.92	3.12	-1.20
Omega ratio Gain probability vs. loss probability	1.23	1.42	-0.19
Calmar ratio Return relative to maximum drawdown	2.54	4.05	-1.51
Martin ratio Return relative to average drawdown	7.77	17.91	-10.14
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

	Risk / Return Rank	Sharpe ratio	Sortino ratio	Omega ratio	Calmar ratio	Martin ratio
MRK Merck & Co., Inc.	83	2.27	3.11	1.39	4.31	12.28
WMT Walmart Inc.	81	1.88	2.75	1.34	5.16	14.19
COST Costco Wholesale Corporation	37	0.22	0.45	1.05	0.54	1.08
JNJ Johnson & Johnson	96	3.93	5.53	1.71	8.78	30.38
BRK-B Berkshire Hathaway Inc.	20	-0.44	-0.49	0.94	-0.17	-0.29
PG The Procter & Gamble Company	17	-0.49	-0.58	0.93	-0.33	-0.62
KO The Coca-Cola Company	54	0.81	1.33	1.15	1.68	3.41
PEP PepsiCo, Inc.	49	0.61	1.09	1.12	1.32	2.60
LLY Eli Lilly and Company	51	0.76	1.26	1.18	1.00	2.43
ABBV AbbVie Inc.	56	0.93	1.39	1.18	1.50	3.48

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Magnum Experiment 48 Sharpe ratios as of Apr 11, 2026 (values are recalculated daily):

1-Year: 1.31
5-Year: 1.11
10-Year: 1.12
All Time: 1.17

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 2.14 to 3.05, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Magnum Experiment 48 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Loading graphics...

Dividends

Dividend yield

Magnum Experiment 48 provided a 1.76% dividend yield over the last twelve months.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Portfolio	1.76%	1.83%	1.82%	2.01%	1.71%	1.71%	2.08%	1.89%	2.09%	2.33%	2.22%	2.50%
Portfolio components:
MRK Merck & Co., Inc.	2.73%	3.12%	3.14%	2.72%	2.52%	3.41%	3.03%	2.48%	2.60%	3.36%	3.14%	3.43%
WMT Walmart Inc.	0.75%	0.84%	0.92%	1.45%	1.58%	1.52%	1.50%	1.78%	2.23%	2.07%	2.89%	3.20%
COST Costco Wholesale Corporation	0.52%	0.59%	0.49%	2.87%	0.76%	0.54%	3.38%	0.86%	1.08%	4.81%	1.09%	4.06%
JNJ Johnson & Johnson	2.18%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%
BRK-B Berkshire Hathaway Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PG The Procter & Gamble Company	2.91%	2.91%	2.36%	2.55%	2.38%	2.08%	2.24%	2.37%	3.09%	2.98%	3.18%	3.31%
KO The Coca-Cola Company	2.66%	2.92%	3.12%	3.12%	2.77%	2.84%	2.99%	2.89%	3.29%	3.23%	3.38%	3.07%
PEP PepsiCo, Inc.	3.62%	3.92%	3.51%	2.91%	2.50%	2.45%	2.71%	2.77%	3.25%	2.64%	2.83%	2.76%
LLY Eli Lilly and Company	0.66%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%
ABBV AbbVie Inc.	3.20%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Magnum Experiment 48. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 48 was 23.48%, occurring on Mar 23, 2020. Recovery took 78 trading sessions.

The current Magnum Experiment 48 drawdown is 4.89%.

Depth	Start	To Bottom	Bottom	To Recover	End	Total
-23.48%	Feb 20, 2020	23	Mar 23, 2020	78	Jul 14, 2020	101
-14.82%	Apr 11, 2022	48	Jun 17, 2022	111	Nov 25, 2022	159
-12.89%	Dec 4, 2018	14	Dec 24, 2018	56	Mar 18, 2019	70
-12.3%	Jan 29, 2018	39	Mar 23, 2018	92	Aug 3, 2018	131
-11.94%	Mar 4, 2025	26	Apr 8, 2025	158	Nov 21, 2025	184

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.

Loading graphics...

Diversification

Diversification Metrics

Number of Effective Assets

The portfolio contains 15 assets, with an effective number of assets of 13.74, reflecting the diversification based on asset allocation. This number of effective assets suggests that the portfolio's investments are spread across a variety of assets, indicating a well-diversified allocation. However, true diversification also depends on the correlations between assets.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

	Benchmark	AAPL	LLY	UNH	ABBV	WMT	MRK	ADBE	HD	COST	KO	PG	JNJ	PEP	V	BRK-B	Portfolio
Benchmark	1.00	0.63	0.41	0.44	0.42	0.38	0.37	0.65	0.60	0.53	0.42	0.39	0.41	0.42	0.67	0.67	0.75
AAPL	0.63	1.00	0.23	0.25	0.22	0.24	0.19	0.48	0.36	0.37	0.23	0.24	0.22	0.27	0.43	0.37	0.49
LLY	0.41	0.23	1.00	0.31	0.41	0.25	0.46	0.27	0.26	0.28	0.26	0.30	0.44	0.28	0.29	0.31	0.55
UNH	0.44	0.25	0.31	1.00	0.33	0.26	0.34	0.28	0.32	0.29	0.30	0.31	0.39	0.31	0.35	0.40	0.53
ABBV	0.42	0.22	0.41	0.33	1.00	0.23	0.44	0.27	0.30	0.24	0.32	0.32	0.46	0.33	0.34	0.37	0.56
WMT	0.38	0.24	0.25	0.26	0.23	1.00	0.25	0.24	0.40	0.57	0.37	0.43	0.33	0.40	0.28	0.36	0.60
MRK	0.37	0.19	0.46	0.34	0.44	0.25	1.00	0.22	0.26	0.24	0.36	0.38	0.50	0.38	0.31	0.37	0.62
ADBE	0.65	0.48	0.27	0.28	0.27	0.24	0.22	1.00	0.41	0.40	0.26	0.25	0.25	0.28	0.56	0.38	0.55
HD	0.60	0.36	0.26	0.32	0.30	0.40	0.26	0.41	1.00	0.47	0.33	0.36	0.33	0.37	0.44	0.47	0.60
COST	0.53	0.37	0.28	0.29	0.24	0.57	0.24	0.40	0.47	1.00	0.37	0.39	0.32	0.39	0.39	0.39	0.65
KO	0.42	0.23	0.26	0.30	0.32	0.37	0.36	0.26	0.33	0.37	1.00	0.60	0.45	0.69	0.37	0.45	0.64
PG	0.39	0.24	0.30	0.31	0.32	0.43	0.38	0.25	0.36	0.39	0.60	1.00	0.48	0.63	0.35	0.40	0.65
JNJ	0.41	0.22	0.44	0.39	0.46	0.33	0.50	0.25	0.33	0.32	0.45	0.48	1.00	0.48	0.36	0.45	0.66
PEP	0.42	0.27	0.28	0.31	0.33	0.40	0.38	0.28	0.37	0.39	0.69	0.63	0.48	1.00	0.36	0.40	0.67
V	0.67	0.43	0.29	0.35	0.34	0.28	0.31	0.56	0.44	0.39	0.37	0.35	0.36	0.36	1.00	0.53	0.63
BRK-B	0.67	0.37	0.31	0.40	0.37	0.36	0.37	0.38	0.47	0.39	0.45	0.40	0.45	0.40	0.53	1.00	0.66
Portfolio	0.75	0.49	0.55	0.53	0.56	0.60	0.62	0.55	0.60	0.65	0.64	0.65	0.66	0.67	0.63	0.66	1.00

The correlation results are calculated based on daily price changes starting from Jan 3, 2013

Magnum Experiment 48

Asset Allocation

Performance

Performance Chart

Returns By Period

Monthly Returns

Benchmark Metrics

Expense Ratio

Return for Risk

Risk / Return Rank

Return / Risk — by metrics

Sharpe ratio

Sortino ratio

Omega ratio

Calmar ratio

Martin ratio

Sharpe Ratio

Dividends

Dividend yield

Drawdowns

Drawdowns Chart

Worst Drawdowns

Volatility

Volatility Chart

Diversification

Diversification Metrics

Number of Effective Assets

Asset Correlations Table